Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Peer

Showing results (21-30 of 181) with videos related to

Pageof 19
Sort By:
ACS Nano|July 21, 2017
Next-Generation Lipids in RNA Interference TherapeuticsStephanie Rietwyk, Dan Peer
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2018
Gene Silencing in the Right Place at the Right TimeAnna Gutkin, Dan Peer
Advanced Drug Delivery Reviews|September 15, 2012
RNAi-based nanomedicines for targeted personalized therapyAla Daka, Dan Peer
Nature|February 25, 2026
Lipid nanoparticles engineered to target therapeutic RNA to the pancreasAviad Elisha, Dan Peer
ACS Nano|April 11, 2013
Harnessing nanomedicine for mucosal theranostics--a silver bullet at last?Eran Elinav, Dan Peer
Science Translational Medicine|July 1, 2016
Zooming in on selectins in cancerRanit Kedmi, Dan Peer
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 17, 2012
Liposomes and other assemblies as drugs and nano-drugs: from basic and translational research to the clinicsYechezkel Barenholz, Dan Peer
Nanomedicine (London, England)|December 5, 2009
RNAi nanoparticles in the service of personalized medicineRanit Kedmi, Dan Peer
Cancer Letters|July 15, 2005
Fluoxetine and reversal of multidrug resistanceDan Peer, Rimona Margalit
Cell Cycle (Georgetown, Tex.)|February 18, 2009
Systemic siRNA delivery to leukocyte-implicated diseasesDan Peer, Motomu Shimaoka
Pageof 19

Showing results (21-30 of 181) with videos related to

Sort By:
Pageof 19
ACS Nano|July 21, 2017
Next-Generation Lipids in RNA Interference TherapeuticsStephanie Rietwyk, Dan Peer
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2018
Gene Silencing in the Right Place at the Right TimeAnna Gutkin, Dan Peer
Advanced Drug Delivery Reviews|September 15, 2012
RNAi-based nanomedicines for targeted personalized therapyAla Daka, Dan Peer
Nature|February 25, 2026
Lipid nanoparticles engineered to target therapeutic RNA to the pancreasAviad Elisha, Dan Peer
ACS Nano|April 11, 2013
Harnessing nanomedicine for mucosal theranostics--a silver bullet at last?Eran Elinav, Dan Peer
Science Translational Medicine|July 1, 2016
Zooming in on selectins in cancerRanit Kedmi, Dan Peer
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 17, 2012
Liposomes and other assemblies as drugs and nano-drugs: from basic and translational research to the clinicsYechezkel Barenholz, Dan Peer
Nanomedicine (London, England)|December 5, 2009
RNAi nanoparticles in the service of personalized medicineRanit Kedmi, Dan Peer
Cancer Letters|July 15, 2005
Fluoxetine and reversal of multidrug resistanceDan Peer, Rimona Margalit
Cell Cycle (Georgetown, Tex.)|February 18, 2009
Systemic siRNA delivery to leukocyte-implicated diseasesDan Peer, Motomu Shimaoka
Pageof 19